J Cancer
2011; 2:347-349.
doi:10.7150/jca.2.347 This volumeCite
Short Report
Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Cancer (RCC)
Marco Bregni✉, Fabio Ciceri, Jacopo Peccatori
Department of Hematology, Istituto Scientifico San Raffaele, Milano, Italy
✉ Corresponding author: Marco Bregni, M.D. Department of Hematology, Istituto Scientifico San Raffaele, Via Olgettina 60, 20132 Milano Italy. Marco.bregniit
Citation:
Bregni M, Ciceri F, Peccatori J. Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Cancer (RCC). J Cancer 2011; 2:347-349. doi:10.7150/jca.2.347. https://www.jcancer.org/v02p0347.htm
A variety of therapeutic options are now available for advanced renal cell cancer, including antiangiogenic and anti-mTOR agents. Allogeneic hematopoietic stem cell transplantation, through its graft-versus-tumor effect, can induce clinical responses and prolonged survival in selected cytokine-refractory patients. However, the still relevant transplant-related mortality due to toxicity and graft-versus-host disease is an obstacle to its widespread use.
Bregni, M., Ciceri, F., Peccatori, J. (2011). Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Cancer (RCC). Journal of Cancer, 2, 347-349. https://doi.org/10.7150/jca.2.347.
ACS
Bregni, M.; Ciceri, F.; Peccatori, J. Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Cancer (RCC). J. Cancer 2011, 2, 347-349. DOI: 10.7150/jca.2.347.
NLM
Bregni M, Ciceri F, Peccatori J. Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Cancer (RCC). J Cancer 2011; 2:347-349. doi:10.7150/jca.2.347. https://www.jcancer.org/v02p0347.htm
CSE
Bregni M, Ciceri F, Peccatori J. 2011. Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Cancer (RCC). J Cancer. 2:347-349.